dc.contributor.author | Ergur, AT | |
dc.contributor.author | Tanzer, F | |
dc.contributor.author | Cetinkaya, O | |
dc.date.accessioned | 2019-07-27T12:10:23Z | |
dc.date.accessioned | 2019-07-28T10:38:43Z | |
dc.date.available | 2019-07-27T12:10:23Z | |
dc.date.available | 2019-07-28T10:38:43Z | |
dc.date.issued | 1997 | |
dc.identifier.issn | 0374-5600 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/11844 | |
dc.description | WOS: A1997XX49700002 | en_US |
dc.description | PubMed ID: 9316280 | en_US |
dc.description.abstract | The serum free carnitine levels of 33 children with recurrent pulmonary infection and 30 healthy children were measured and found to be 26.12 +/- 0.98 nmol/mL and that of the control group 38.98 +/- 0.79 nmol/mL on the average. The mean free carnitine level was statistically determined to be significantly lower when compared with that of the control group (P < 0.01). The results indicate that oral L-carnitine therapy is recommended for pediatric patients with recurrent pulmonary infection. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | BLACKWELL SCIENCE | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | carnitine | en_US |
dc.subject | recurrent pulmonary infection | en_US |
dc.title | Serum free carnitine levels in children with recurrent pulmonary infections | en_US |
dc.type | article | en_US |
dc.relation.journal | ACTA PAEDIATRICA JAPONICA | en_US |
dc.contributor.department | CUMHURIYET UNIV,FAC MED,DEPT PEDIAT,SIVAS,TURKEY -- CUMHURIYET UNIV,FAC MED,DEPT BIOCHEM,SIVAS,TURKEY | en_US |
dc.identifier.volume | 39 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.endpage | 408 | en_US |
dc.identifier.startpage | 406 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |